SCHEMBL406309

SCHEMBL406309

CCc1cc(Oc2cnc3cc(Cl)ccc3n2)ccc1C1C(=O)C(C)(C)OC(C)(C)C1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.42
CYP2C19 P33261 3/20 0.42
CYP2C9 P11712 2/20 0.42
CYP3A4 P08684 5/20 0.40
LMNA P02545 4/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
TP53 P04637 2/20 0.40
MAPT P10636 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALOX15 P16050 1/20 0.40
NFKB1 P19838 1/20 0.40
HIF1A Q16665 1/20 0.40
GMNN O75496 1/20 0.40
APEX1 P27695 1/20 0.40
PMP22 Q01453 1/20 0.40
HTT P42858 5/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HRH4 Q9H3N8 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3713558 0.83 CYP1A2 (0.42) CYP1A2CYP2C19CYP2C9CYP3A4LMNA
SCHEMBL10192898 0.81 CYP1A2 (0.41) CYP1A2CYP2C19CYP2C9CYP3A4LMNA
SCHEMBL1742467 0.80 ALDH1A1 (0.38) LMNAALDH1A1TAAR1PPARGSLC6A4
SCHEMBL10195149 0.78 CYP1A2 (0.40) CYP1A2CYP2C19CYP2C9CYP3A4LMNA
SCHEMBL10195481 0.74 CYP1A2 (0.38) CYP1A2CYP2C19CYP2C9CYP3A4LMNA
SCHEMBL401462 0.74 CYP1A2 (0.41) CYP1A2CYP2C19CYP2C9CYP3A4LMNA
SCHEMBL406549 0.74 MAPK1 (0.51) LMNANPSR1MAPT
SCHEMBL406720 0.72 CTSD (0.40) CYP1A2CYP2C19CYP2C9CYP3A4ALDH1A1
SCHEMBL407385 0.72 CYP1A2 (0.39) CYP1A2CYP2C19CYP2C9CYP3A4LMNA
SCHEMBL10192930 0.72 ALDH1A1 (0.40) CYP1A2CYP2C19CYP2C9CYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9102642-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and methods of controlling weeds SYNGENTA LIMITED (GB) 2015-08-11 US disclosed
EP-2393796-B1 NOVEL HERBICIDES SYNGENTA LTD (GB) 2015-02-25 EP disclosed
US-20120021909-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
EP-2393796-A1 NOVEL HERBICIDES Syngenta Limited (GB) 2011-12-14 EP disclosed
WO-2010089211-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120021909-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 CYP1A2 67/4885CYP2C19 601/4885CYP2C9 249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.